Skip to main content

Closed

EVGN: Evogene Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-30.9% / yr

Operating margin-757.2%

ROIC-100.8%

Financially safe

Stretched

Debt / equity-0.80×

Interest coverage-2.6×

Current ratio2.77×

Evogene Ltd.

EVGNNASDAQ Global Market·USD·Closed

Evogene Ltd.

EVGNNASDAQ·USD·Closed

$0.47

−3.76%

$0.47

−$0.02 (3.76%)

52W Range

9thpctl

Volume

0.04×avg

Mkt Cap

4.06MUSD

P/E

-0.4TTM

Div Yield

–ann

52W Range

9thpctl

Volume

0.04×avg

Market Cap

4.06MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings